Fill Finish Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2027

Fill Finish Manufacturing Market By Product (Consumables [Prefilled Syringes, Vials, Cartridges, And Others], Instruments [By System Type {Integrated And Standalone}, By Machine Type {Automated, Semi-Automated And Manual}], By End-User (Contract Manufacturing Organizations, Pharmaceutical & Biopharmaceutical Companies, And Others), and by geography is estimated to register growth at a remarkable CAGR forecast during 2022-2027 owing to the growing demand for fill finish manufacturing, along with the rising technological advancement and merger acquisitions during the given forecast period.

The global Fill Finish Manufacturing Market was valued at USD 9,592.89 million in 2021, growing at a CAGR of 9.99% during the forecast period from 2022 to 2027 to reach USD 16,947.87 million by 2027. The Fill Finish Manufacturing Market is slated to witness prosperity owing to factors such as the growing demand for fill-finish manufacturing processes owing to a variety of diseases, requiring less human intervention and minimal chances of contamination. The rising technological developments in the fill-finish manufacturing market along with merger acquisitions taking place in the sector are further expected to result in appreciable revenue growth for the fill-finish manufacturing market during the forecast period (2022-2027).

Fill Finish Manufacturing Market Dynamics:

Among the noteworthy drivers of the fill-finish manufacturing market, is the rising demand for fill-finish manufacturing in recent times owing to the prevalence of a variety of diseases such as oncological and neurological, and the onset of COVID-19, among others. According to the World Health Organization (2022), 400,000 children develop cancer every year on average. The source further stated that cancer caused 10 million deaths worldwide in 2020, such as lung, breast, colon & rectum, and prostate cancer. Moreover, as per WHO (2022), around 55 million people are currently living with dementia, and this number is expected to rise to 78 million in 2030 and 139 million in 2050. All the given conditions would require medical assistance in the form of therapies, biologics, and other drugs that may be beneficial in sustaining the life of the patient, thus increasing the market demand for the fill-finish manufacturing market in the upcoming years.

Also, the rising merger acquisitions in the fill-finish manufacturing market are expected to spur the market demand for high-quality grade drugs and instruments during the forecast period. For instance, in January 2020, the Alcami Corporation, a provider of fully-integrated custom, end-to-end custom solutions for pharmaceutical and biologics industries acquired TriPharm Services, a new-state-of the-art sterile fill-finish manufacturing center solutions, located in North Carolina. Such recent developments help in the expansion of fill-finish services to be provided to a broader spectrum of people, thus driving the overall market for the fill-finish manufacturing market positively during the given forecast period.

However, the high costs of fill-finish products and increased chances of contamination with a lack of trained professionals and others would lead to less adoption and accessibility of fill-finish manufacturing by underdeveloped or developing countries, thus acting as restraints for the market growth of fill-finish manufacturing.

The fill-finish manufacturing market saw enormous growth during the period of COVID- 19 pandemic. Owing to the rising cases of COVID- 19, the demand and the immediate surge in the production of drugs and biologics exponentially increased. Moreover, the research and developmental activities to develop vaccines and their manufacturing requirement on a large scale worldwide, further pushed the growth of the fill-finish manufacturing market. In addition, the opening of widescale manufacturing units and industries, and the increasing demand for the production of drugs and potential biologics for mass immunization to prevent any further pandemics in the future, are expected to uplift the overall fill-finish manufacturing market during the forecast period from 2022-2027.

Fill Finish Manufacturing Market Segment Analysis:

Fill Finish Manufacturing Market by product (consumables [prefilled syringes, vials, cartridges, and others], instruments [by system type {integrated and standalone}, by machine type {automated, semi-automated and manual}], by end-user (contract manufacturing organizations, pharmaceutical & biopharmaceutical companies, and others), and geography (North America, Europe, Asia-Pacific, and Rest of the World).

Based on the product segment of the Fill Finish Manufacturing Market, the consumables category is projected to register a significant growth in revenue in the overall Fill Finish Manufacturing Market during the forecast period (2022-2027).

This can be ascribed to the increasing use of consumables, the subsequent need for new consumables to maintain sterile conditions, and the rising technological developments in the form of product launches are expected to drive the demand for consumables in the product segment of the fill-finish manufacturing market.

Consumables include various types of syringes, vials, and other types of equipment that can be only used once and need to be discarded, to maintain sterile conditions. The increasing use of consumables such as vials in lyophilization, and their growing use for disposable packaging in biologics are the various factors owing to which the product segment is driving the demand for the fill-finish manufacturing market.

Thereby, considering the growing demand for this segment, numerous new products are being launched in the market. For example, in October 2021, West Pharmaceutical introduced the DeltaCube Modeling Platform and NovaGaurd SA Pro Safety System for 0.5mL standard glass syringes at Interphex.

Therefore, considering the advantages and the wide applicability associated with the consumables category in the product segment, this segment is expected to generate considerable revenue thereby pushing the overall growth of the global Fill Finish Manufacturing Market during the forecast period.

Asia-Pacific is expected to register the fastest growth in CAGR in the Global Fill-Finish Manufacturing Market:

Among all the regions, Asia-Pacific is expected to register the fastest growth in CAGR in the global Fill Finish Manufacturing Market. This can be ascribed to factors such as the increasing investments by companies in clinical research, significant improvements in healthcare infrastructure, the growing construction of fill-finish facilities, and the rising product development activities in the region. For instance, in August 2021, Lonza added capacity at its biologics manufacturing facility in Guangzhou, China, by installing a new fill-finish line unit. In addition, with the costs of material and labor being comparatively cheaper in countries such as India and China, the manufacturing process of the fill-finish market becomes easy, thus driving the global market for the fill-finish manufacturing market. Along with this, the rapid expansion of the biopharmaceutical industry could be a major factor driving the demand for fill-finish manufacturing in the region.

Countries in the Asia-Pacific region such as India and China, being the largest exporters to western companies, have increased their production of APIs. For instance, in August 2020, Wockhardt Ltd, headquartered in Mumbai, India announced a deal with the U.K. government which would supply millions of doses of numerous COVID-19 vaccines, as well as those being formed by AstraZeneca and Oxford University. As part of the deal, the company had also confined fill-and-finish capacity, being the final production step of putting vaccines into syringes or vials and packaging them.

Therefore, the above-mentioned factors are expected to bolster the growth and register a significant CAGR in the Fill Finish Manufacturing Market in the Asia-Pacific region during the forecast period.

Fill Finish Manufacturing Market Key Players:

Some of the key market players operating in the Fill Finish Manufacturing Market include Becton, Dickinson and Company, Syntegon Technology GmbH, Industria Macchine Automatiche S.p.A., Stevanato Group, West Pharmaceutical Services, Inc., OPTIMA Packaging Group GmbH, Bausch+Strobel, Groninger & Co. GmbH, Gerresheimer AG, Maquinaria Industrial Dara, Robert Bosch, SGD Pharma, Schott AG, Nipro Corporation, Bausch Advanced Technology Group, VanRX Pharmasystems Inc., Aseptic Technologies, Reagent Chemical & Research Inc., AST, Steriline S.R.L, and others.

Recent Developmental Activities in the Fill-Finish Manufacturing Market:

• In March 2022, SGD pharma launched its ready-to-use sterile 100 ml molded glass vials, which are used for fill finish parental drug products. These glass vials help in proper drug stability and eliminate the chances of scratch on vials to enhance visual inspection.
• In February 2022, Moderna and Thermo Fisher scientific underwent long-term strategic collaboration to bolster the range of aseptic fill-finish manufacturing of Spikevax, Covid-19 vaccines, and different mRNA medicines in the US.
• In October 2021, West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced the unveiling of its DeltaCube™ Modeling Platform as well as the new NovaGuard® SA Pro Safety System for ISO 0.5mL Standard Glass Syringes at Interphex.

Key Takeaways from the Fill-Finish Manufacturing Market Report Study

• Market size analysis for current fill-finish manufacturing market size (2021), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the fill-finish manufacturing market.
• Top key product developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the global fill-finish manufacturing market.
• Various opportunities available for the other competitor in the fill-finish manufacturing market space.
• What are the top-performing segments in 2021? How these segments will perform in 2027.
• Which are the top-performing regions and countries in the current fill-finish manufacturing market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for fill-finish manufacturing market growth in the coming future?

Target Audience who can be benefited from this Fill-Finish Manufacturing Market Report Study

• Fill Finish Manufacturing products providers
• Research organizations and consulting companies
• Fill Finish Manufacturing-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Fill Finish Manufacturing
• Various distribution channels who want to know more about the Fill Finish Manufacturing market and the latest product innovations in the Fill Finish Manufacturing market.

Frequently Asked Questions for the Fill-Finish Manufacturing Market:

1. What is Fill Finish Manufacturing?
Fill Finish Manufacturing refers to the process of filling vials, syringes, and other storage types of equipment with the vaccine, biological & pharmaceutical drug substances along with proper packaging for mass distribution.

2. What is the market for global Fill Finish Manufacturing?
The global Fill Finish Manufacturing Market was valued at USD 9,592.89 million in 2021, growing at a CAGR of 9.99% during the forecast period from 2022 to 2027 to reach USD 16,947.87 million by 2027.

3. What are the drivers for the global Fill Finish Manufacturing market?
The Fill Finish Manufacturing market is slated to witness prosperity owing to factors such as the growing demand for fill-finish manufacturing processes, requiring less human intervention and minimal chances of contamination. The rising technological developments in the fill-finish manufacturing market along with merger acquisitions taking place in the sector are further expected to result in appreciable revenue growth for the fill-finish manufacturing market during the forecast period (2022-2027).

4. Who are the key players operating in the global Fill Finish Manufacturing market?
Some of the key market players operating in the Fill Finish Manufacturing Market include Becton, Dickinson and Company, Syntegon Technology GmbH, Industria Macchine Automatiche S.p.A., Stevanato Group, West Pharmaceutical Services, Inc., OPTIMA Packaging Group GmbH, Bausch+Strobel, Groninger & Co. GmbH, Gerresheimer AG, Maquinaria Industrial Dara, Robert Bosch, SGD Pharma, Schott AG, Nipro Corporation, Bausch Advanced Technology Group, VanRX Pharmasystems Inc., Aseptic Technologies, Reagent Chemical & Research Inc., AST, Steriline S.R.L, and others.

5. Which region has the fastest-growing CAGR in the Fill Finish Manufacturing Market?
The Asia-Pacific region is expected to have the fastest-growing CAGR in the overall Fill Finish Manufacturing Market during the forecast period from 2022 to 2027. This can be ascribed to factors such as the increasing investments by companies in clinical research, significant improvements in healthcare infrastructure, the growing construction of fill-finish facilities, and the rising product development activities in the region.


This product will be delivered within 3-5 business days.